STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells
BABIJ, Carol, YIHONG ZHANG, FAJARDO, Flordeliza, JACKSON, Angela, ZONDLO, James, YU SUN, ELLISON, Aaron R, PLEWA, Cherylene A, SAN MIGUEL, Tisha, ROBINSON, John, MCCARTER, John, SCHWANDNER, Ralf, KURZEJA, Robert J, JUDD, Ted, CARNAHAN, Josette, DUSSAULT, Isabelle, MUNZLI, Anke, SHEHABELDIN, Amro, FERNANDO, Manory, QUON, Kim, KASSNER, Paul D, RUEFLI-BRASSE, Astrid A, WATSON, Vivienne J
Published in Cancer research (Chicago, Ill.) (01.09.2011)
Published in Cancer research (Chicago, Ill.) (01.09.2011)
Get full text
Journal Article
Utilization of human nuclear receptors as an early counter screen for off-target activity: a case study with a compendium of 615 known drugs
Fan, Fan, Hu, Rong, Munzli, Anke, Chen, Yuan, Dunn, 2nd, Robert T, Weikl, Kerstin, Strauch, Simone, Schwandner, Ralf, Afshari, Cynthia A, Hamadeh, Hisham, Nioi, Paul
Published in Toxicological sciences (01.06.2015)
Published in Toxicological sciences (01.06.2015)
Get full text
Journal Article
Abstract 253: Identification of STK33 kinase inhibitors for the validation of a synthetic lethal relationship between STK33 and mutant KRAS
Zhang, Yihong, Kurzeja, Robert, Munzli, Anke, Zondlo, James, Miguel, Tisha San, Robinson, John, McCarter, John, Schwandner, Ralf, Judd, Ted, Fernando, Manory, Babij, Carol, Carnahan, Josette, Dussault, Isabelle
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article